Treatment of metastasis.
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002371:Cat Diseases / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D002415:Cats; D003520:Cyclophosphamide / Q000008:administration & dosage; D004283:Dog Diseases / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D004285:Dogs; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation / Q000662:veterinary; D005260:Female; D007157:Immunologic Surveillance; D008207:Lymphatic Metastasis; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000662:veterinary*; D009360:Neoplastic Cells, Circulating
D004317:Doxorubicin; D003520:Cyclophosphamide